Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 9Anemia, Aplastic 9Leukemia 8Lymphoma 6Leukemia, Myeloid, Acute 5Myeloproliferative Disorders 4Multiple Myeloma 4Hodgkin Disease 4Primary Myelofibrosis 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hematologic Neoplasms 3Polycythemia Vera 2Neutropenia, Severe Congenital, Autosomal Recessive 3 2Immunologic Deficiency Syndromes 2Histiocytosis 2Hemoglobinuria, Paroxysmal 2Congenital Abnormalities 2Bone Marrow Failure Disorders 2Blast Crisis 2Anemia, Sickle Cell 2Anemia, Refractory, with Excess of Blasts 2Anemia, Diamond-Blackfan 2beta-Thalassemia 1Thrombocythemia, Essential 1Shwachman-Diamond Syndrome 1Recurrence 1Primary Immunodeficiency Diseases 1

Interventions

fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Melphalan 1Cyclophosphamide 1Clinical Trials, Phase I as Topic 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metabolism, Inborn Errors × Alemtuzumab × Classical hematology × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡